Mauna Kea Wins FDA Clearance for Confocal Miniprobes

May 26, 2016

Mauna Kea Technologies has secured FDA clearance for its Confocal Miniprobes for use with the company’s Cellvizio platform, the French devicemaker announced Wednesday.

The device is designed for use in urological and minimally invasive surgical applications, and provides real time microscopic visualization. — Anisa Jibrell


View today's stories